The largest database of trusted experimental protocols

8 protocols using ki67 pe cy7

1

Comprehensive T Cell Immunophenotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed on whole blood and BAL samples obtained from all 21 animals as previously described.25 , 33 (link) For T cell phenotyping the following antibodies were used: CD3 V500 (1:50, clone SP34-2), CD4 PerCP-Cy5.5 (1:10, clone L200), CD8 PE-TxRed (1:30, clone RPA-T8), CD28 APC (1:5, clone CD28.2), CD69 APC-Cy7 (1:20, clone FN50), CD95 PE-Cy5 (1:5, clone DX2), CD183 AL488 (1:10, clone 1C6/CXCR3), CD184 PE-Cy5 (1:5, clone 12G5), CD195 APC (1:5, clone 3A9), CD197 PE-Cy7 (1:20, clone 3D12), HLA-DR APC-Cy7 (1:75, clone L243), and Ki67 PE-Cy7 (1:50, clone B56) all purchased from BD Biosciences (San Jose, CA, USA). Flow cytometry analyses were conducted by gating first on lymphocytes followed by the elimination of B cells by gating for CD20. The remaining cells were gated for the selection of T cells using CD3, followed by gating into CD3+CD4+ and CD3+CD8+ subpopulations. The frequencies of CD4+ and CD8+ T cells expressing activation and homing markers were compared using Ki67, CXCR3, CCR5, and CCR7.70 (link) The levels of Foxp3+ were determined as a measure of the Treg response. Finally, the extent of CD4+ and CD8+ cells belonging to either central memory (TCM) or effector memory (TEM) relative to the naïve T cell population were measured using a combination of CD28 and CD95 markers.37 (link)
+ Open protocol
+ Expand
2

Comprehensive T-cell Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed on whole-blood and BAL samples obtained from all 21 animals as previously described25 (link)33 (link). For T-cell phenotyping, the following antibodies were used: CD3 V500 (1:50, clone SP34-2), CD4 PerCP-Cy5.5 (1:10, clone L200), CD8 PE-TxRed (1:30, clone RPA-T8), CD28 APC (1:5, clone CD28.2), CD69 APC-Cy7 (1:20, clone FN50), CD95 PE-Cy5 (1:5, clone DX2), CD183 AL488 (1:10, clone 1C6/CXCR3), CD184 PE-Cy5 (1:5, clone 12G5), CD195 APC (1:5, clone 3A9), CD197 PE-Cy7 (1:20, clone 3D12), HLA-DR APC-Cy7 (1:75, clone L243) and Ki67 PE-Cy7 (1:50, clone B56) all purchased from BD Biosciences (San Jose, CA, USA). Flow cytometry analyses were conducted by gating first on lymphocytes followed by the elimination of B cells by gating for CD20. The remaining cells were gated for the selection of T cells using CD3, followed by gating into CD3+CD4+ and CD3+CD8+ subpopulations. The frequencies of CD4+ and CD8+ T cells expressing activation and homing markers were compared using Ki67, CXCR3, CCR5 and CCR7 (ref. 70 (link)). The levels of Foxp3+ were determined as a measure of the Treg response. Finally, the extent of CD4+ and CD8+ cells belonging to either TCM or TEM relative to the naive T-cell population were measured using a combination of CD28 and CD95 markers37 (link).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies from BD Biosciences (Franklin Lakes, NJ) were used for staining: CD8-FITC (53.67), CD8-APC (KT15), Foxp3-PE (FJK-16s), CD3-AF700 (17A2), CD44-PerCP-Cy5.5 (IM7), CD4-FITC (RM4– 5), CD62L-BV421 (MEL-14), CD25-APC (PC61), Ki67-PE-Cy7 (SolA15), CTLA-4-PE (UC10–4F10–11), PD-1-BV421 (RMP1–30), granzyme B-PE (NGZB), OX40-BV711 (OX86), GITR-BV510 (DTA-1). MHC class I-restricted (H2-Db) PE-labeled CEA-tetramer (sequence: EAQNTTYL) was purchased from MBL International Corporation (Woburn, MA). Live/Dead fixable aqua stain and transcription factor staining buffer set were purchased from Thermo Fisher (Waltham, MA). Flow cytometry was performed on BD LSRFortessa or BD FACSVerse (BD Biosciences) and analyzed using FlowJo v.9.7.6 or v.10.5.3 (TreeStar). Cell viability was examined using trypan blue staining prior to data acquisition. Live cells were gated via forward and side scatter. Isotype control staining was <5% for all samples analyzed.
+ Open protocol
+ Expand
4

Comprehensive Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: APC labeled PBS57 loaded CD1d-tetramers from the NIH tetramer facility, TCRβ APC-e780 (H57-597, eBiosciences) or Pacific Blue (H57-597, Biolegend), CD44 AlexaFluor(AF)700 (IM7, Biolegend), CD45.2 Pacific Blue (104, Biolegend), Thy1.1 phycoerythrin (PE) (A85-1, BD Pharmingen), Thy1.2 FITC (53-2.1, BD Pharmingen), NK1.1 PE-Cy7 or PE (PK136, BD Pharmingen), or Pacific Blue (PK136, Biolegend), or NK1.1-biotin (PK136, eBiosciences) followed by streptavidin-PE Texas Red, CD24 PerCPCy5.5 (M1/69, eBiosciences) or FITC or PE (M1/69, BD Pharmingen), IL-17A PE (17B7, eBiosciences), IL-4 PE-Cy7 (BVD6-24G2, eBiosciences), IFN-γ PerCPCy5.5 (XMG1.2, Biolegend), cMyc (Y69, abcam) or p27kip1 (D69C12; Cell Signaling Technology) followed by anti-rabbit IgG PE (Life Sciences), Ki67-PeCy7 (B56, BD Pharmingen), rabbit IgG isotype (Life Technologies) and BrdU (BrdU flow kit; BD Pharmingen). For transcription factor staining, cells were incubated with antibody to PLZF (D-9, Santa Cruz), followed by anti-mouse IgG1 PE (A85-1, eBiosciences), and then T-bet PE-Cy7 (4B10, eBiosciences), GATA3 PerCpCy5.5 (TWAJ, eBiosciences), and RORγt-BV421 (Q31-378, BD Biosciences).
+ Open protocol
+ Expand
5

Immunostaining and Flow Cytometry Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Abs were used for IF and IHC staining: anti-mouse IgA Ab-PE (Abcam, 97013) or fluorescein isothiocyanate (FITC; Abcam, 97234), anti-mouse CD138-PE (clone 281-2, BioLegend), anti-human IgA (DAKO, #IR51061), or CD138 (DAKO, M7228). For flow cytometry, the following Abs against mouse antigens were used: B220–APC-Cy7 (clone RA3-6B2, BioLegend), CD138-PE or BV421 (clone 281-2), GL7-PerCP Cy5.5 (clone GL7, BioLegend), Ki67–PE-Cy7 (clone B56, BD), IgG1-FITC (clone A85-1, BD), IgG2a/c-FITC (clone RMG2a-62, BioLegend), IgG2b-FITC (SouthernBiotech, 1092-02), IgG3-FITC (SouthernBiotech, 1102-02), IgA-biotin (clone RMA-1, BioLegend), CD73-biotin (clone TY/11.8, BioLegend), CD140b-APC (clone APB5, BioLegend), CD105–PE-Cy7 (clone MJ7/18, BioLegend), CD45–PerCP-Cy5.5 (clone 30-F11, BioLegend), and CD31-PE (clone 390, BioLegend); other reagents were also used: rabbit polyclonal anti-SPTBN1 (amino acids 2100 to 2150; Abcam, 72239), normal rabbit IgG (an isotype-matched control for the latter; Sigma-Aldrich, 12-370), anti-rabbit IgG-BV421 (clone Poly4064, BioLegend), streptavidin-BV421 (BioLegend, 405226), or APC (BioLegend, 405207).
+ Open protocol
+ Expand
6

Comprehensive Multiparametric Immunophenotyping of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
As part of the original A5314 study, cryopreserved PBMC specimens from A5314 (n=118) were thawed and stained with LiveDead Yellow (ThermoFisher), CD3-BV711 (clone UCHT1, BD), CD4-AlexaFluor(AF)-700 (RPA-T4, BD), CD8-BrilliantViolet(BV)-785 (RPA-T8, BD), HLA-DR-FITC (L243, BD), CD38-APC (HIT2, BD), CD14-Pacific Blue (M5E2, BD), CD16-APC-Cy7 (3G8, BioLegend), CX3CR1-PerCP-Cy5.5 (2A9-1, BioLegend), and CD69-PE-Cy7 (L78, BD). Additional aliquots of cryopreserved PBMCs from each donor at baseline and week 24 were then thawed and stained with a second panel, consisting of LiveDead Aqua (ThermoFisher), CD3-BV605 (SK7, BD), CD4-BrilliantUltraViolet(BUV)395 (SK3, BD), CD8-APC-Cy7 (SK1, BioLegend), CD45RA-APC (HI100, BD), CD27-BV786 (O323, BioLegend), CD95-PE (DX2, BD), CD127-PECF594 (A0195D5, BioLegend), CD39-PerCPCy5.5 (eBioA1, eBioscience), CD73-BV421 (AD2, BioLegend), Ki67-PECy7 (B56, BD), and Bcl-2-FITC (Bcl-2/100, BD). All researchers remained blinded to the treatment status of the donors during flow cytometry acquisition and gating.
+ Open protocol
+ Expand
7

Multiparameter Immune Profiling of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen PBMCs were thawed in Dulbecco’s Phosphate Buffered Saline. Antibody panels and staining protocols were established prior to the experiments. Each sample was incubated with fixable viability dye (Fixable Viability Stain 780, BD Biosciences) at room temperature for 10 min to rule out dead cells. After washed twice, Fc block (BD Biosciences) was added to significantly reduce potential non-specific antibody staining. Immune cell subset distribution was assessed by flow cytometry using two panels of antibodies against cell surface markers. Lymphocyte panel: CD3 PerCP-Cy5.5 (BD Biosciences), CD4 FITC (BD Biosciences), CD8 APC (BD Biosciences), CD25 BV421 (BD Biosciences), CD127 PE (BD Biosciences), CD19 APC-R700 (BD Biosciences), CD56 BV605 (BD Biosciences). MDSC panel: CD33 APC (BD Biosciences), CD11b FITC (BD Biosciences), HLA-DR PE (BD Biosciences), CD14 PerCP-Cy5.5 (BD Biosciences), CD15 BV421(BD Biosciences). For lymphocyte panel, after incubation of 30 min at 4 °C, cells were washed and permeabilized with fixation/permeabilization buffer (Transcription Factor Buffer Set, BD Biosciences) for 45 min at 4℃, followed by intracellular staining with Ki67 PE-Cy7 (BD Biosciences) for 45 min at 4℃ and two washes. Fluorescence minus one (FMO) controls were used for Ki67 PE-Cy7, CD11b FITC and HLA-DR PE.
+ Open protocol
+ Expand
8

Intracellular Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intracellular staining was performed using FOXP3 Fixation/Permeabilization Buffer (Biolegend -421403) according to the manufacturer instructions.
Antibodies used in this study were the following: TruStain fcX (anti-mouse CD16/32) (Biolegend -101320), CD3-BV711 (BD -563123), CD4-PECF594 (BD -562285), CXCR3-APC (BD -562266), CD44-V450 (BD -560451), Ki67-PECy7 (BD -561283), CD8a (KT15)-FITC (Proimmune 1705F/33790).
The data were acquired using BD LSR-FORTESSA flow cytometer and subsequently analyzed using FlowJo software v10.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!